- Report
- November 2023
- 131 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- April 2018
- 470 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Report
- September 2023
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2023
- 150 Pages
United States
From €3770EUR$3,950USD£3,159GBP
From €5679EUR$5,950USD£4,758GBP
- Report
- September 2021
- 40 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- July 2021
- 50 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- June 2021
- 50 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- May 2021
- 50 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- May 2021
- 50 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- February 2024
- 129 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- January 2022
- 119 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2022
- 120 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2024
- 140 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- May 2022
- 120 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- January 2024
- 143 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- November 2023
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- November 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- November 2023
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- November 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically.
The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer.
In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more